Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Where Will Vaxart Be in 1 Year?
06:50am, Saturday, 06'th Mar 2021
A flaw in the logic behind a big sell-off may lead to a big surprise sometime in 2021.
Should You Buy Vaxart Stock in March?
06:00am, Saturday, 06'th Mar 2021
The clinical-stage vaccine-focused biotech recently offered investors a glimmer of hope about its COVID-19 candidate.
Vaxart to Present at the H.C. Wainwright Global Life Sciences Conference
04:01pm, Thursday, 04'th Mar 2021
SOUTH SAN FRANCISCO, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet
Vaxart Stock Remains a Buy as Unique Covid-19 Vaccine Is Developed
10:33am, Tuesday, 02'nd Mar 2021
There are plenty of entrants in the race to develop a Covid-19 vaccine, but distinct advantages mark VXRT stock as a worthy biotech holding. The post Vaxart Stock Remains a Buy as Unique Covid-19 Vacc
VAXART, INC. (VXRT) Moves 5.6% Higher: Will This Strength Last?
05:19am, Tuesday, 02'nd Mar 2021
VAXART, INC. (VXRT) witnessed a jump in share price last session on above-average trading volume.
Is Vaxart Stock Set To Decline Further?
10:00am, Monday, 01'st Mar 2021
Vaxart stock (NASDAQ: VXRT) dropped -8% over the last five trading days and has underperformed the S&P 500 which remained roughly flat over the same period. The stock is also down by about -27% over t
Could Vaxart Be a Millionaire-Maker Stock?
06:04am, Monday, 01'st Mar 2021
The short answer: maybe.
Vaxart to Provide 2021 Business Outlook on Tuesday, March 2, 2021
04:01pm, Wednesday, 24'th Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by
How Risky Is Vaxart?
07:47am, Wednesday, 24'th Feb 2021
Let's look at what short-sellers are saying and what science is saying.
VAXART, INC. (VXRT) Stock Sinks As Market Gains: What You Should Know
06:55pm, Tuesday, 23'rd Feb 2021
In the latest trading session, VAXART, INC. (VXRT) closed at $6.79, marking a -0.73% move from the previous day.
VAXART, INC. (VXRT) Dips More Than Broader Markets: What You Should Know
06:58pm, Wednesday, 17'th Feb 2021
VAXART, INC. (VXRT) closed the most recent trading day at $7.94, moving -1.85% from the previous trading session.
Hedge Fund Diaries: Who Was Buying Your Stocks?
06:11pm, Wednesday, 17'th Feb 2021
SEC 13Fs reveal trades from months ago, but also patterns of long-term bullish behavior.
Vaxart (VXRT) to Report Q4 Earnings: What's in the Cards?
10:36am, Wednesday, 17'th Feb 2021
On Vaxart's (VXRT) fourth-quarter earnings call, investor focus will be on the company's progress with the development of its oral COVID-19 vaccine candidate, VXA-CoV2-1.
Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vaxart
06:30am, Monday, 15'th Feb 2021
The choice isn't easy, but simplicity may be the answer.
What Is Vaxart Worth Now?
10:47am, Friday, 12'th Feb 2021
The company can still produce returns without a COVID vaccine.
